513 related articles for article (PubMed ID: 24620821)
1. Organs-on-a-chip: a new tool for drug discovery.
Polini A; Prodanov L; Bhise NS; Manoharan V; Dokmeci MR; Khademhosseini A
Expert Opin Drug Discov; 2014 Apr; 9(4):335-52. PubMed ID: 24620821
[TBL] [Abstract][Full Text] [Related]
2. Successes and future outlook for microfluidics-based cardiovascular drug discovery.
Skommer J; Wlodkowic D
Expert Opin Drug Discov; 2015 Mar; 10(3):231-44. PubMed ID: 25672221
[TBL] [Abstract][Full Text] [Related]
3. Organs-on-a-chip for drug discovery.
Selimović S; Dokmeci MR; Khademhosseini A
Curr Opin Pharmacol; 2013 Oct; 13(5):829-33. PubMed ID: 23850526
[TBL] [Abstract][Full Text] [Related]
4. Advances in microfluidics for drug discovery.
Lombardi D; Dittrich PS
Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
[TBL] [Abstract][Full Text] [Related]
5. Organ/body-on-a-chip based on microfluidic technology for drug discovery.
Kimura H; Sakai Y; Fujii T
Drug Metab Pharmacokinet; 2018 Feb; 33(1):43-48. PubMed ID: 29175062
[TBL] [Abstract][Full Text] [Related]
6. Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.
Lee JB; Sung JH
Biotechnol J; 2013 Nov; 8(11):1258-66. PubMed ID: 24038956
[TBL] [Abstract][Full Text] [Related]
7. The latest advances in high content screening in microfluidic devices.
Liu W; Wang J; Qi H; Jiao Q; Wu L; Wang Y; Liang Q
Expert Opin Drug Discov; 2023 Jul; 18(7):781-795. PubMed ID: 37219918
[TBL] [Abstract][Full Text] [Related]
8. OrganDots--an organotypic 3D tissue culture platform for drug development.
Sundstrom L; Biggs T; Laskowski A; Stoppini L
Expert Opin Drug Discov; 2012 Jun; 7(6):525-34. PubMed ID: 22607235
[TBL] [Abstract][Full Text] [Related]
9. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
10. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
Cavero I; Guillon JM; Holzgrefe HH
Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
[TBL] [Abstract][Full Text] [Related]
11. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
12. Industrial lab-on-a-chip: design, applications and scale-up for drug discovery and delivery.
Vladisavljević GT; Khalid N; Neves MA; Kuroiwa T; Nakajima M; Uemura K; Ichikawa S; Kobayashi I
Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1626-63. PubMed ID: 23899864
[TBL] [Abstract][Full Text] [Related]
13. Organs-on-chips at the frontiers of drug discovery.
Esch EW; Bahinski A; Huh D
Nat Rev Drug Discov; 2015 Apr; 14(4):248-60. PubMed ID: 25792263
[TBL] [Abstract][Full Text] [Related]
14. Liver microphysiological platforms for drug metabolism applications.
Kulsharova G; Kurmangaliyeva A
Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
[TBL] [Abstract][Full Text] [Related]
15. Organ-on-a-chip platforms for studying drug delivery systems.
Bhise NS; Ribas J; Manoharan V; Zhang YS; Polini A; Massa S; Dokmeci MR; Khademhosseini A
J Control Release; 2014 Sep; 190():82-93. PubMed ID: 24818770
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
Low LA; Tagle DA
Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
[TBL] [Abstract][Full Text] [Related]
18. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.
Skardal A; Murphy SV; Devarasetty M; Mead I; Kang HW; Seol YJ; Shrike Zhang Y; Shin SR; Zhao L; Aleman J; Hall AR; Shupe TD; Kleensang A; Dokmeci MR; Jin Lee S; Jackson JD; Yoo JJ; Hartung T; Khademhosseini A; Soker S; Bishop CE; Atala A
Sci Rep; 2017 Aug; 7(1):8837. PubMed ID: 28821762
[TBL] [Abstract][Full Text] [Related]
19. The application of engineered liver tissues for novel drug discovery.
Lin C; Ballinger KR; Khetani SR
Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
[TBL] [Abstract][Full Text] [Related]
20. Organs-on-chips technologies - A guide from disease models to opportunities for drug development.
Monteduro AG; Rizzato S; Caragnano G; Trapani A; Giannelli G; Maruccio G
Biosens Bioelectron; 2023 Jul; 231():115271. PubMed ID: 37060819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
